New York State Common Retirement Fund’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,200
Closed -$10.4K 3208
2025
Q1
$10.4K Hold
21,200
﹤0.01% 3080
2024
Q4
$18.2K Hold
21,200
﹤0.01% 3055
2024
Q3
$180K Sell
21,200
-17,700
-46% -$104K ﹤0.01% 2350
2024
Q2
$182K Buy
+38,900
New +$184K ﹤0.01% 2469
2022
Q3
Sell
-140
Closed 3271
2022
Q2
$0 Sell
140
-12,200
-99% -$20K ﹤0.01% 3470
2022
Q1
$26K Hold
12,340
﹤0.01% 3266
2021
Q4
$110K Sell
12,340
-54
-0.4% -$709 ﹤0.01% 3048
2021
Q3
$206K Sell
12,394
-4,130
-25% -$71.3K ﹤0.01% 2903
2021
Q2
$343K Buy
16,524
+4,224
+34% +$80K ﹤0.01% 2787
2021
Q1
$231K Hold
12,300
﹤0.01% 2782
2020
Q4
$271K Hold
12,300
﹤0.01% 2624
2020
Q3
$255K Hold
12,300
﹤0.01% 2542
2020
Q2
$445K Buy
12,300
+6,500
+112% +$272K ﹤0.01% 2279
2020
Q1
$190K Hold
5,800
﹤0.01% 2483
2019
Q4
$158K Buy
5,800
+4,800
+480% +$82.2K ﹤0.01% 2837
2019
Q3
$11K Buy
+1,000
New +$9.44K ﹤0.01% 3212

Other funds holding APLT

New York State Common Retirement Fund's APLT Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 21,200 shares — an estimated $10.4K sold.

New York State Common Retirement Fund first reported a position in APLT in Q3 2019 and held it in 16 quarters. The position peaked at $445K in Q2 2020. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 21,200 Applied Therapeutics shares in Q2 2025, an estimated $10.4K.
  • New York State Common Retirement Fund first reported a position in Applied Therapeutics in Q3 2019 and held it in 16 quarters.
  • New York State Common Retirement Fund's Applied Therapeutics position peaked at $445K in Q2 2020.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.